Viewing nowCombinationTelostop Plus Tablet 80/5/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.

MFDS item code 201801977 · Approved 2018.05.10 · Insurance code 642905990
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular diseases
This medication is used for patients with hypertension who do not achieve adequate blood pressure control with telmisartan and amlodipine alone, as well as for patients who require concomitant use of rosuvastatin. The combination of telmisartan and amlodipine effectively lowers blood pressure, aiding in the treatment of essential hypertension. Rosuvastatin is used as an adjunct in patients with hypercholesterolemia and mixed dyslipidemia that are not controlled by diet and exercise. It is also applicable to patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. This medication helps lower total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease. Thus, it is used to simultaneously manage hypertension and dyslipidemia, improving cardiovascular health.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single-ingredient product may switch to this medicine (a combination product with the same amount of each active ingredient) for convenience. ○ Telmisartan/Amlodipine Combination Before treatment with the telmisartan/amlodipine combination, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of the day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of rosuvastatin 40 mg is contraindicated in some of these patients.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately after pregnancy is confirmed. Do not take this medication if you have an allergy to any ingredient in this product or similar medications, or have a history of angioedema. It is not safe for patients with severely impaired liver or kidney function, patients with severe heart valve disease, or those in a state of shock. Elderly patients or those with hypotension, hyperkalemia, or liver dysfunction must use this medication with caution, and regular monitoring of liver function and muscle condition is required. If symptoms such as muscle pain, weakness, or cramps occur during treatment with this medication, consult a doctor immediately, and perform blood tests to check for muscle damage if necessary. Be aware that interactions may occur when this medication is taken with certain other drugs, so inform your doctor or pharmacist about any other medications you are taking. Women who may become pregnant should use appropriate contraceptive methods while taking this medication, and breastfeeding should be avoided or this medication should not be taken. This medication is not recommended for children under 18 due to insufficient safety and efficacy data. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmia may occur, warranting immediate medical attention, with treatment tailored to the symptoms. Keep this medication out of the reach of children, and avoid transferring it to another container to maintain the quality and safety of the drug.
Viral upper respiratory infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, discomfort in the oropharynx, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasms, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependency edema, angina pectoris, rapid heartbeat, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory disturbances, involuntary muscle contractions, anxiety, depression, nervous irritability, allergies, fever, leg pain, listlessness, asthma, bronchitis, rhinitis, epistaxis, dermatitis, rash, eczema, pruritus, angioedema, frequent urination, cystitis, increased sweating, erectile dysfunction, constipation, nausea, abdominal pain, pancreatitis, vasculitis, peripheral neuropathy, tremors, dysphagia, gingival hyperplasia, allergic reactions, burning sensation, rigidity, weight gain, weight loss, sexual dysfunction, insomnia, abnormal dreams, depersonalization, angioedema, erythema multiforme, erythematous rash, papular rash, diplopia, eye pain, urination disorders, nocturia, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, pruritus, myalgia, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms-associated drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, amnesia, peripheral neuropathy, angioedema, thrombocytopenia, elevated serum creatinine, acute renal failure, oliguria, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. It is important to keep the storage temperature between 1 to 30 degrees Celsius at room temperature to maintain its effect and safety over time.
Round film-coated tablet in bright pink color
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.